These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8589544)

  • 1. An exact representation for the generating function for the Moolgavkar-Venzon-Knudson two-stage model of carcinogenesis with stochastic stem cell growth.
    Denes J; Krewski D
    Math Biosci; 1996 Jan; 131(2):185-204. PubMed ID: 8589544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A numerical solution to the nonhomogeneous two-stage MVK model of cancer.
    Crump KS; Subramaniam RP; Van Landingham CB
    Risk Anal; 2005 Aug; 25(4):921-6. PubMed ID: 16268939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll.
    Little MP
    Biometrics; 1995 Dec; 51(4):1278-91. PubMed ID: 8589222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the exact hazard and survival functions of the MVK stochastic carcinogenesis model.
    Zheng Q
    Risk Anal; 1994 Dec; 14(6):1081-4. PubMed ID: 7846316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States.
    Herrero-Jimenez P; Tomita-Mitchell A; Furth EE; Morgenthaler S; Thilly WG
    Mutat Res; 2000 Jan; 447(1):73-116. PubMed ID: 10686307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extending the stochastic two-stage model of carcinogenesis to include self-regulation of the nonmalignant cell population.
    Cox LA
    Risk Anal; 1992 Mar; 12(1):129-38. PubMed ID: 1574612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A stem cell model for carcinogenesis.
    Kopp-Schneider A; Portier CJ
    Math Biosci; 1994 Apr; 120(2):211-32. PubMed ID: 8204985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To use or not to use? Backward equations in stochastic carcinogenesis models.
    Zheng Q
    Biometrics; 1998 Mar; 54(1):384-8. PubMed ID: 9544530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nonidentifiability aspect of the two-stage model of carcinogenesis.
    Hanin LG; Yakovlev AYu
    Risk Anal; 1996 Oct; 16(5):711-5. PubMed ID: 8962520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two stage model for carcinogenesis: number and size distributions of premalignant clones in longitudinal studies.
    Dewanji A; Goddard MJ; Krewski D; Moolgavkar SH
    Math Biosci; 1999 Jan; 155(1):1-12. PubMed ID: 10024832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment of nongenotoxic carcinogens based upon cell proliferation/death rates in rodents.
    Gaylor DW; Zheng Q
    Risk Anal; 1996 Apr; 16(2):221-5. PubMed ID: 8638041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A probability generating function method for stochastic reaction networks.
    Kim P; Lee CH
    J Chem Phys; 2012 Jun; 136(23):234108. PubMed ID: 22779582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stochastic simulation of a multistage model of carcinogenesis.
    Sherman CD; Portier CJ
    Math Biosci; 1996 May; 134(1):35-50. PubMed ID: 8935954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data.
    Little MP; Wright EG
    Math Biosci; 2003 Jun; 183(2):111-34. PubMed ID: 12711407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some properties of the hazard function of the two-mutation clonal expansion model.
    Heidenreich WF; Luebeck EG; Moolgavkar SH
    Risk Anal; 1997 Jun; 17(3):391-9. PubMed ID: 9232020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculating tumor incidence rates in stochastic models of carcinogenesis.
    Portier CJ; Kopp-Schneider A; Sherman CD
    Math Biosci; 1996 Jul; 135(2):129-46. PubMed ID: 8768218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis.
    Dragan YP; Hully J; Baker K; Crow R; Mass MJ; Pitot HC
    Toxicology; 1995 Sep; 102(1-2):161-75. PubMed ID: 7482551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States.
    Herrero-Jimenez P; Thilly G; Southam PJ; Tomita-Mitchell A; Morgenthaler S; Furth EE; Thilly WG
    Mutat Res; 1998 May; 400(1-2):553-78. PubMed ID: 9685710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling lung tumour risk in radon-exposed uranium miners using generalizations of the two-mutation model of Moolgavkar, Venzon and Knudson.
    Little M; Haylock RG; Muirhead CR
    Int J Radiat Biol; 2002 Jan; 78(1):49-68. PubMed ID: 11747553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a biologically-based controlled growth and differentiation model for developmental toxicology.
    Whitaker SY; Tran HT; Portier CJ
    J Math Biol; 2003 Jan; 46(1):1-16. PubMed ID: 12525932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.